-----------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 5, 2005
OCCULOGIX, INC.
(Exact name of Registrant as specified in its Charter)
Delaware 000 51030 59-343-4771
(State or other Jurisdiction) (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
2600 Skymark Avenue, Unit 9, Suite 201
Mississauga, Ontario L4W 5B2
(Address of principal executive offices)
Registrant's telephone number, including area code: (905) 602-0887
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
----------------------------------------------------------------------------
ITEM 2.02 Results of Operations and Financial Condition
On May 5, 2005, the Company issued a press release announcing financial results
for the three months ended March 31, 2005. A copy of the press release is
attached as an exhibit to this Current Report.
ITEM 9.01 Financial Statements and Exhibits
(c) Exhibits
99.1 Press Release of OccuLogix, Inc. dated May 5, 2005.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
OCCULOGIX, INC.
Date: May 9, 2005
By: /s/ William G. Dumencu
----------------------------
William G. Dumencu
Chief Financial Officer